Search clinical trials for: SBRT

Total 907 results

Regina Elena Cancer Institute

Recruiting

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer (STUNNIN)

Prostate Cancer

Italy
Memorial Sloan Kettering Cancer Center

Recruiting

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Breast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast Carcinoma

United States
Sun Yat-sen University
Chongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen... and other collaborators

Recruiting

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC

China
National Taiwan University Hospital

Recruiting

Post Operative RT for Limited Spine Metastases

Spine Metastases

Taiwan
Abramson Cancer Center at Penn Medicine

Recruiting

SBRT With Atezo/Bev for HCC

Hepatocellular Carcinoma

United States
Peking University Third Hospital

Not yet recruiting

Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute

Recruiting

Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer (IMCORT-2)

Non-small Cell Lung Cancer Metastatic

China
Alexander Chi

Not yet recruiting

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage II

China
Huazhong University of Science and Technology

Recruiting

SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC

Metastatic Colorectal Cancer

China
VA Ann Arbor Healthcare System
Lungevity

Recruiting

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Liver Metastases

United States
Sun Yat-sen University

Recruiting

Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
West China Hospital

Recruiting

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Prostate Cancer | Efficacy | Safety | Stereotactic Body Radiotherapy | High-risk

China
Lambda Therapeutic Research Ltd.
Intas Pharmaceutical Limited (Biopharma Division)

Recruiting

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

India
Peking University Third Hospital

Not yet recruiting

The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer

Stereotactic Body Radiation Therapy

China
RefleXion Medical

Recruiting

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System (PREMIER)

Cancer | Cancer, Gastrointestinal | Cancer Central Nervous System | Cancer Thoracic | Cancer Gynecologic | Cancer, Genito-Urinary | Cancers Lymphatic | Cancer Head and Neck

United States
Kantonsspital Winterthur KSW
Krebsforschung Schweiz, Bern, Switzerland

Recruiting

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases (SMILE)

Pain | Bone Metastases | Radiation Therapy

Switzerland
Taofeek Owonikoko
AstraZeneca

Recruiting

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Extensive-stage Small-cell Lung Cancer

United States
The Netherlands Cancer Institute
Genzyme, a Sanofi Company

Recruiting

Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC (RAD-IO)

Carcinoma, Non-Small-Cell Lung

Netherlands
Zhejiang Cancer Hospital

Recruiting

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

NSCLC Stage IV

China
Memorial Sloan Kettering Cancer Center
Pfizer

Recruiting

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

Mucosal Melanoma

United States
University of Colorado, Denver
Merck Sharp & Dohme LLC

Recruiting

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

Gastric Cancer | GastroEsophageal Cancer

United States
UMC Utrecht

Not yet recruiting

Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites (SIRIUS)

Metastatic Colorectal Cancer | Oligometastatic Disease

Netherlands
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Lymphoma | Metastatic Malignant Solid Neoplasm

United States
Zhuang Hongqing

Not yet recruiting

Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics

Spinal Tumor | Prognosis | Radiomics | Stereotactic Radiosurgery

China
University Health Network, Toronto

Recruiting

MR-guided Tumour Boost (MRL-Boost)

Prostate Cancer

Canada
National Cancer Institute (NCI)

Recruiting

T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Cancer Of Prostate

United States
Rigshospitalet, Denmark
Odense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaborators

Recruiting

A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY). (STRICTSTARLUNG)

Lung Cancer | Radiotherapy Side Effect | Metastases to Lung

Denmark
Universitaire Ziekenhuizen KU Leuven

Recruiting

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer (SPARKLE)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate Cancer

Belgium
Peking University Third Hospital

Recruiting

Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites

Thoracic Cancer | Radiotherapy | Safety and Efficacy

China
Universitaire Ziekenhuizen KU Leuven

Recruiting

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer (OBELIX PCa)

Prostate Cancer | Radiotherapy | SBRT

Belgium
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study (SAMURAI)

Metastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma

United States
Centre hospitalier de l'Université de Montréal...

Recruiting

Increased Early Pain Relief by Adding Vertebroplasty to SBRT

Pain | Spine Metastases | Radiation Therapy

Canada
University of Texas Southwestern Medical Center
NeoTract, Inc.

Recruiting

UroLift System With SAbR for Prostate Cancer and BPH

Prostate Cancer

United States
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 Inhibitor

China
National Taiwan University Hospital

Not yet recruiting

Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Unresectable Hepatocellular Carcinoma | Pembrolizumab | Stereotactic Body Radiotherapy | Lenvatinib

Taiwan
Lawson Health Research Institute

Recruiting

PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) (ARGOS/CLIMBER)

Prostate Cancer

Canada
Amsterdam UMC, location VUmc
UMC Utrecht; Erasmus Medical Center; Dutch Cancer Society; Viewray Inc.

Recruiting

Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients (PANCOSAR)

Pancreatic Cancer Non-resectable

Netherlands
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)

Metastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder Cancer

France
Campus Bio-Medico University

Recruiting

Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients (BoMB)

Stage IV Breast Cancer

Italy
Instituto de Investigación en Oncología Radioterápica...
Instituto de Investigación en Oncología Radioterápica FEOR (IRAD-FEOR)

Recruiting

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC (START-MET)

Prostate Cancer | Stereotactic Body Radiation Therapy

Spain
Peking University Third Hospital

Recruiting

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Recurrent Cancer | Stereotactic Body Radiation Therapy | Thoracic Tumor | Irradiation; Reaction

China
Yonsei University

Recruiting

Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma

Oligometastasis Hepatocellular Carcinoma

Korea, Republic of
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Prostate Cancer

United States
Yonsei University

Not yet recruiting

The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Korea, Republic of
Wuhan University

Not yet recruiting

The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer

Recurrent Small Cell Lung Cancer
Jun-Lin Yi, MD

Not yet recruiting

Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) (LM-HNSCC)

Head and Neck Squamous Cell Carcinoma | Immunotherapy | Metastases | Stereotactic Body Radiotherapy

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Prostate Cancer

United States
Ludwig-Maximilians - University of Munich
University of Zurich; Heidelberg University

Recruiting

MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC (MASPAC)

Pancreatic Cancer

Germany, Switzerland
Fang Wu
Xiangya Hospital of Central South University; Hunan Cancer Hospital; The Third...

Recruiting

The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE) (SMILE)

The Efficacy and Safety of SBRT in MPLC

China

Search clinical trials for: SBRT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations